Tanimola Akande
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tanimola Akande has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Aina Olufemi Odusola
Dept of Global Health, Academic Medical Center, University of Amsterdam, Pietersbergweg 17, Amsterdam, 1105 BM, The Netherlands
3 shared publications - Constance Schultsz
Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
3 shared publications - Kayode Agbede
Ogo Oluwa Hospital, 64/65 Ahmadu Bello Way, Bacita, Kwara State, Nigeria.
3 shared publications - Akin Osibogun
University of Lagos College of Medicine
2 shared publications - Joep Lange
Dept of Global Health, Academic Medical Center, University of Amsterdam, Pietersbergweg 17, Amsterdam, 1105 BM, The Netherlands
2 shared publications - Joke A. Haafkens
Department of General Practice, Academic Medical Centre, Amsterdam, the Netherlands
2 shared publications
Latest Publications
- Open Access
- 10 December 2014
- Published by Springer Nature in BMC Health Services Research
- Vol. 14 (1) , 624
Perceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study
Universal health care coverage has been identified as a promising strategy for improving hypertension treatment and control rates in sub Saharan Africa (SSA). Yet, even when quality care is accessible, poor adherence can compromise treatment outcomes. To provide information for adherence support interventions, this study explored what low income patients who received hypertension care in the context of a community based health insurance program in Nigeria perceive as inhibitors and facilitators for adhering to pharmacotherapy and healthy behaviors. We conducted a qualitative interview study with 40 insured hypertensive patients who had received hypertension care for > 1 year in a rural primary care hospital in Kwara state, Nigeria. Supported by MAXQDA software, interview transcripts were inductively coded. Codes were then grouped into concepts and thematic categories, leading to matrices for inhibitors and facilitators of treatment adherence. Important patient-identified facilitators of medication adherence included: affordability of care (through health insurance); trust in orthodox “western” medicines; trust in Doctor; dreaded dangers of hypertension; and use of prayer to support efficacy of pills. Inhibitors of medication adherence included: inconvenient clinic operating hours; long waiting times; under-dispensing of prescriptions; side-effects of pills; faith motivated changes of medication regimen; herbal supplementation/substitution of pills; and ignorance that regular use is needed. Local practices and norms were identified as important inhibitors to the uptake of healthier behaviors (e.g. use of salt for food preservation; negative cultural images associated with decreased body size and physical activity). Important factors facilitating such behaviors were the awareness that salt substitutes and products for composing healthier meals were cheaply available at local markets and that exercise could be integrated in people’s daily activities (e.g. farming, yam pounding, and household chores). With a better understanding of patient perceived inhibitors and facilitators of adherence to hypertension treatment, this study provides information for patient education and health system level interventions that can be designed to improve compliance. ISRCTN47894401 .
- 10 December 2014
- Published by Springer Nature in BMC Health Services Research
- Vol. 14 (1) , 624
Open AccessPerceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study
Universal health care coverage has been identified as a promising strategy for improving hypertension treatment and control rates in sub Saharan Africa (SSA). Yet, even when quality care is accessible, poor adherence can compromise treatment outcomes. To provide information for adherence support interventions, this study explored what low income patients who received hypertension care in the context of a community based health insurance program in Nigeria perceive as inhibitors and facilitators for adhering to pharmacotherapy and healthy behaviors. We conducted a qualitative interview study with 40 insured hypertensive patients who had received hypertension care for > 1 year in a rural primary care hospital in Kwara state, Nigeria. Supported by MAXQDA software, interview transcripts were inductively coded. Codes were then grouped into concepts and thematic categories, leading to matrices for inhibitors and facilitators of treatment adherence. Important patient-identified facilitators of medication adherence included: affordability of care (through health insurance); trust in orthodox “western” medicines; trust in Doctor; dreaded dangers of hypertension; and use of prayer to support efficacy of pills. Inhibitors of medication adherence included: inconvenient clinic operating hours; long waiting times; under-dispensing of prescriptions; side-effects of pills; faith motivated changes of medication regimen; herbal supplementation/substitution of pills; and ignorance that regular use is needed. Local practices and norms were identified as important inhibitors to the uptake of healthier behaviors (e.g. use of salt for food preservation; negative cultural images associated with decreased body size and physical activity). Important factors facilitating such behaviors were the awareness that salt substitutes and products for composing healthier meals were cheaply available at local markets and that exercise could be integrated in people’s daily activities (e.g. farming, yam pounding, and household chores). With a better understanding of patient perceived inhibitors and facilitators of adherence to hypertension treatment, this study provides information for patient education and health system level interventions that can be designed to improve compliance. ISRCTN47894401 .
- 1 March 2014
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 32 (3) , 487-494
Target organ damage among hypertensive adults in rural Nigeria
Objectives: To study the prevalence of target organ damage (TOD) in hypertensive adults in a general population in rural Nigeria, to assess determinants of TOD and the contribution of TOD screening to assess eligibility for antihypertensive treatment. Methods: All adults diagnosed with hypertension (n = 387) and a random sample (n = 540) out of all nonhypertensive adults, classified during a household survey in 2009, had a blood pressure measurement and were invited for TOD (myocardial infarction, left ventricular hypertrophy, angina pectoris, kidney disease) screening in 2011. Results: Participation in TOD screening was 51% (n = 196) in respondents with hypertension and 33% (n = 179) in those without hypertension. TOD prevalence in hypertensive and nonhypertensive adults was 32 and 15%, respectively. Hypertension severity was a strong determinant for TOD [grade 1 odds ratio (OR) 2.66, 95% confidence interval (CI)1.04–6.84; grade 2 OR 3.82, 95% CI 1.41–10.36]. Out of 196 hypertensive patients, 151 were untreated, of whom all grade 2 hypertensive patients (n = 71) were eligible for treatment. Screening revealed TOD in 19 out of 80 grade 1 hypertensive respondents (24%), therefore also classifying them as eligible for treatment. TOD screening hypertensive nonrespondents had more severe hypertension than hypertensive respondents, which may have resulted in an underestimation of the true prevalence of TOD among adults with hypertension. Conclusion: A high prevalence of 32% TOD in hypertensive adults in rural Nigeria was observed. Almost a quarter of respondents with grade 1 hypertension were eligible for antihypertensive treatment based on TOD screening findings. As TOD screening is mostly unavailable in sub-Saharan Africa, we propose antihypertensive treatment for all patients with hypertension.
- 1 March 2014
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 32 (3) , 487-494
Target organ damage among hypertensive adults in rural Nigeria
Objectives: To study the prevalence of target organ damage (TOD) in hypertensive adults in a general population in rural Nigeria, to assess determinants of TOD and the contribution of TOD screening to assess eligibility for antihypertensive treatment. Methods: All adults diagnosed with hypertension (n = 387) and a random sample (n = 540) out of all nonhypertensive adults, classified during a household survey in 2009, had a blood pressure measurement and were invited for TOD (myocardial infarction, left ventricular hypertrophy, angina pectoris, kidney disease) screening in 2011. Results: Participation in TOD screening was 51% (n = 196) in respondents with hypertension and 33% (n = 179) in those without hypertension. TOD prevalence in hypertensive and nonhypertensive adults was 32 and 15%, respectively. Hypertension severity was a strong determinant for TOD [grade 1 odds ratio (OR) 2.66, 95% confidence interval (CI)1.04–6.84; grade 2 OR 3.82, 95% CI 1.41–10.36]. Out of 196 hypertensive patients, 151 were untreated, of whom all grade 2 hypertensive patients (n = 71) were eligible for treatment. Screening revealed TOD in 19 out of 80 grade 1 hypertensive respondents (24%), therefore also classifying them as eligible for treatment. TOD screening hypertensive nonrespondents had more severe hypertension than hypertensive respondents, which may have resulted in an underestimation of the true prevalence of TOD among adults with hypertension. Conclusion: A high prevalence of 32% TOD in hypertensive adults in rural Nigeria was observed. Almost a quarter of respondents with grade 1 hypertension were eligible for antihypertensive treatment based on TOD screening findings. As TOD screening is mostly unavailable in sub-Saharan Africa, we propose antihypertensive treatment for all patients with hypertension.
- Open Access
- 25 March 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 186
Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I)
Cardiovascular diseases (CVD) are a leading contributor to the burden of disease in low- and middle-income countries. Guidelines for CVD prevention care in low resource settings have been developed but little information is available on strategies to implement this care. A community health insurance program might be used to improve patients' access to care. The operational research project "QUality Improvement Cardiovascular care Kwara - I (QUICK-I)" aims to assess the feasibility of CVD prevention care in rural Nigeria, according to international guidelines, in the context of a community based health insurance scheme.
- 25 March 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 186
Open AccessCardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I)
Cardiovascular diseases (CVD) are a leading contributor to the burden of disease in low- and middle-income countries. Guidelines for CVD prevention care in low resource settings have been developed but little information is available on strategies to implement this care. A community health insurance program might be used to improve patients' access to care. The operational research project "QUality Improvement Cardiovascular care Kwara - I (QUICK-I)" aims to assess the feasibility of CVD prevention care in rural Nigeria, according to international guidelines, in the context of a community based health insurance scheme.
- Open Access
- 21 March 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 171
Development and evaluation of a patient centered cardiovascular health education program for insured patients in rural Nigeria (QUICK - II)
In Sub Saharan Africa, the incidence of hypertension and other modifiable cardiovascular risk factors is growing rapidly. Poor adherence to prescribed prevention and treatment regimens by patients can compromise treatment outcomes. Patient-centered cardiovascular health education is likely to improve shortcomings in adherence. This paper describes a study that aims to develop a cardiovascular health education program for patients participating in a subsidized insurance plan in Nigeria and to evaluate the applicability and effectiveness in patients at increased risk for cardiovascular disease.
- 21 March 2011
- Published by Springer Nature in BMC Public Health
- Vol. 11 (1) , 171
Open AccessDevelopment and evaluation of a patient centered cardiovascular health education program for insured patients in rural Nigeria (QUICK - II)
In Sub Saharan Africa, the incidence of hypertension and other modifiable cardiovascular risk factors is growing rapidly. Poor adherence to prescribed prevention and treatment regimens by patients can compromise treatment outcomes. Patient-centered cardiovascular health education is likely to improve shortcomings in adherence. This paper describes a study that aims to develop a cardiovascular health education program for patients participating in a subsidized insurance plan in Nigeria and to evaluate the applicability and effectiveness in patients at increased risk for cardiovascular disease.
- 1 September 2007
- Vol. 36 (3) , 207-11
Influence of drug promotion on prescribing habits of doctors in a teaching hospital.
This descriptive cross-sectional survey was conducted at University of Ilorin Teaching Hospital to examine the influence of drug promotion by drug companies on the prescription habits of doctors in the hospital. Self-administered questionnaires were used to collect information from 137 doctors selected across all the clinical and laboratory departments using proportionate sampling. Majority (89.0%) of the doctors had attended drug promotion forum and were exposed to 64 different branded drugs within 6 months to this study. Fifty percent of the doctors had prescribed promoted drugs for the first time within 6 months to this study and over two-thirds agreed that drug promotion materials served as incentives to prescribe promoted drugs in preference to their alternatives. More than two-thirds of the doctors did not prescribe in generic names, thus making them susceptible to prescribing promoted branded drugs. Drug promotion by drug companies influence prescription habits of doctors in this teaching hospital. This finding though beneficial to the drug companies may not necessarily be cost-effective and to the benefit of the patients. Further studies and attention on this issue in developing countries is necessary with the ultimate aim of protecting the interest of patients in the face of rising cost of pharmaceuticals.
- 1 September 2007
- Vol. 36 (3) , 207-11
Influence of drug promotion on prescribing habits of doctors in a teaching hospital.
This descriptive cross-sectional survey was conducted at University of Ilorin Teaching Hospital to examine the influence of drug promotion by drug companies on the prescription habits of doctors in the hospital. Self-administered questionnaires were used to collect information from 137 doctors selected across all the clinical and laboratory departments using proportionate sampling. Majority (89.0%) of the doctors had attended drug promotion forum and were exposed to 64 different branded drugs within 6 months to this study. Fifty percent of the doctors had prescribed promoted drugs for the first time within 6 months to this study and over two-thirds agreed that drug promotion materials served as incentives to prescribe promoted drugs in preference to their alternatives. More than two-thirds of the doctors did not prescribe in generic names, thus making them susceptible to prescribing promoted branded drugs. Drug promotion by drug companies influence prescription habits of doctors in this teaching hospital. This finding though beneficial to the drug companies may not necessarily be cost-effective and to the benefit of the patients. Further studies and attention on this issue in developing countries is necessary with the ultimate aim of protecting the interest of patients in the face of rising cost of pharmaceuticals.